Kemnay Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Kemnay Advisory Services's REGN Position: Q2 2026 in Review
Kemnay Advisory Services increased its Regeneron Pharmaceuticals (REGN) stake by 4.9% in Q2 2026, buying an estimated $1.36K and bringing the position to 43 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #562.
Kemnay Advisory Services first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $31.7K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Kemnay Advisory Services held 43 shares of Regeneron Pharmaceuticals worth $26.8K as of Q2 2026.
- Kemnay Advisory Services bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #562 holding.
- Kemnay Advisory Services first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Kemnay Advisory Services's Regeneron Pharmaceuticals position peaked at $31.7K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.